NIH-funded research R01 grant

How prenatal marijuana affects the placenta and infant brain growth

Official title: Placental Genomics in the Developmental Consequences of Marijuana Use in Pregnancy

Funded at Miriam Hospital · NIH-11324952 · Data updated 2026-11-12

This project will look at how marijuana use during pregnancy changes the placenta and might affect an infant's growth and brain development.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMiriam Hospital
NIH-funded
Lab location1 site (Providence, United States)
Project startJune 1, 2023
Project endMarch 31, 2028
Funding year2026
Award (this year)$675,274
NIH project number5R01DA056787-04
Project IDNIH-11324952 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant people (and their newborns) who used marijuana during pregnancy and are willing to provide placental tissue at birth and participate in follow-up visits.

Less likely to help

People who are not pregnant, who did not have prenatal marijuana exposure, or who cannot provide placental samples or follow-up data are unlikely to benefit directly from this work.

What this research studies

If you used marijuana while pregnant, researchers may collect your placenta at delivery and analyze its gene activity to see how exposure relates to newborn size and early brain development. They will compare placental genomic patterns from pregnancies with and without cannabis exposure and link those patterns to infant outcomes in an ongoing mother-infant cohort. The team uses advanced genomic profiling to find biological pathways and biomarkers that could signal fetal harm from prenatal cannabis. Results aim to point to targets for future screening or interventions to help exposed children.

Why it matters

Potential benefit: Could identify placental markers that help detect or prevent harms from prenatal marijuana exposure and guide future care for exposed infants.

How similar studies have gone: Earlier work by this team has linked prenatal cannabis to infant outcomes and other studies show placental genomics can reflect prenatal exposures, but comprehensive genomic study of cannabis exposure is relatively new.

Where this research is happening

  • Miriam Hospital
    Providence, United States
    Active

Researchers

  • Principal investigator: Stroud, Laura R — Miriam Hospital
  • Study coordinator: Stroud, Laura R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.